Thieves Market #ACR22 Amoebic arthritis - is it rare? Case from Indonesia After the case, found it in 3 other synovial fluids! Rx with surgery, metronidazole - later rx for post-ifn arthritis and gout @RheumNow https://t.co/oi8PqtTTyc

Severe subtype of #sJIA HLADRB1*15:01 known to be associated with adverse drug reactions to biologics. prospective cohort - 65pts. - Anakinra effective irrespective of HLADRB1*15:01 - No difference in eosinophilia - Recommend not to wait to start tx @rheumnow #ACR22 abst#L12 https://t.co/LX5lMJOKRf

Alert 🚨 New imaging technology MSOT = combination of US and photo acoustic imaging Detects metabolites in enthesis and synovitis 🫱🏼>Hb and O2 saturation correlate w/ Doppler+ 🫱🏼>Hb & collagen correlate w/ calcifications https://t.co/X18fGFVh5L Abs#2205 #ACR22 @RheumNow https://t.co/84BU5YUrCz

• Non-Invasive in Vivo Metabolic Profiling of Inflammation in Joints and Entheses…

RA really does still impact employment outcomes for many, despite T2T. @earlyarthritis🇨🇦 data in working age people show many back in the game in the first year, but not many more after that. Plenty more to do to get all our pts back to their best! ABST1967 #ACR22 @RheumNow https://t.co/isD1rgkFoH

SURPASS was a head-to-head study comparing SEC vs ADA biosimilar (SDZ-ADL) in r-axSpA on spinal radio progression: Results showed no significant diff in spinal radio progression bet. the 2 grps. Biosimilars remain tx options for r-axSpA. #ACR22 @RheumNow ABST#L15

Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ active foot involvement have higher scores anyway (driven by physician & patient global) but examining feet would have only changed management in 3.1%. @RheumNow ABST0265 #ACR22 https://t.co/ckuB8R4ZTF

Response to ULT in Hyperuricaemia +non episodic foot pain not meeting criteria for gout classification predicted by 🔥US findings of 👉double contour sign 👉tophus Abst 1828 #ACR22 @FloodRachael @RheumNow https://t.co/ATzEgFOWU0

PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose of PCV13 at day 0 and day 7 followed by a single dose of PPV23 at M5. More data needed on this updated, clinical strategy. Abs L16 #ACR22 @RheumNow https://t.co/m71VQMGZ68

• Innovative Anti-pneumococcal Vaccine Strategies versus Standard Vaccination Reg…

Polymyalgia rheumatica: more than just steroids at #ACR22 After decades of having little else proven apart from glucocorticosteroids with which to treat PMR, evidence for steroid-sparing options has grown in recent years. https://t.co/CjMzEqRan8 https://t.co/5UixhVemqY

• https://bit.ly/3hIcfTf

SMS/email reminders slightly improve fluvax uptake in RA pts (nested RCT within ART registry, France) ABST2002 #ACR22 @RheumNow @philipcrobinson & I wrote @TheLancetRheum on how to improve preventative med https://t.co/55j8rdv3nV I think we need multiple simultaneous strategies! https://t.co/pNfpWLVkac

• Preventive medicine in rheumatology: COVID-19 and its lessons for better health…

Big change for #SLE Trials coming soon. My exclusive interview w/Prof @EricFMorand. Future trials will likely incorporate this Novel Treatment Response Measurement (TRM) Tool #ACR22 @rheumnow https://t.co/TXsxJi3qhC

• A Novel Treatment Response Measurement Tool for Lupus | RheumNow

Our work presented at #ACR22 showing increased mast cells and tryptase activity in women with OA compared to men! Food for thought - can simple allergy meds help in OA management? @RheumNow abst#1642. https://t.co/cBQZU5MXeR

• https://twitter.com/HSpecialSurgery/status/1592155451126599680

Cancer risk with tofacitinib vs TNFi in RA: we learned at #ACR21 that CV-enriched pts: risk (ORAL Surveillance) all comers: no risk (STAR-RA) French national healthcare database #ACR22 looks at all comers: nothing to separate tofa and TNFi. Risk begets risk ABST1984 @RheumNow https://t.co/0GG04NSP3D https://t.co/nwQz7fx21M

• https://twitter.com/drdavidliew/status/1458414766871904259

Based on your experience, will you attend #ACR23 next year ... @ACRheum @rheumnow

⚡️Pulmonary pulse wave transit time⚡️ 👉novel non-invasive echo measure of ⬆️pulm vasc tone in pulm HTN 👉hyperuricaemic pts ⬇️pPTT sugg of pulm vasc dysfn @FloodRachael #ACR22 Abst1788 @RheumNow https://t.co/ZEORWbqw6f